| Literature DB >> 22170700 |
Alexandre Murza1, Alexandre Parent, Elie Besserer-Offroy, Hugo Tremblay, Félix Karadereye, Nicolas Beaudet, Richard Leduc, Philippe Sarret, Éric Marsault.
Abstract
Apelin is the endogenous ligand of the APJ receptor, a member of the G-protein-coupled receptor family. The apelin-APJ complex has been detected in many tissues and is emerging as a promising target for several pathophysiological conditions. There is currently little information on the structure-activity relationship (SAR) of the apelin hormone. In an effort to better delineate SAR, we synthesized analogues of apelin-13 modified at selected positions with unnatural amino acids, with a particular emphasis on the C-terminal portion. Analogues were then tested in binding and functional assays by evaluating Gi/o-mediated decreases in cAMP levels and by assessing β-arrestin2 recruitment to the APJ receptor. The plasma stability of new compounds was also assessed. Several analogues were found to possess increased binding and higher stability than the parent peptide.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22170700 DOI: 10.1002/cmdc.201100492
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466